IDEAS home Printed from https://ideas.repec.org/a/pai/apunup/es-40-07.html
   My bibliography  Save this article

La Convención sobre Diversidad Biológica: una perspectiva de economía política

Author

Listed:
  • Frank G. Miller

Abstract

Este ensayo intenta evaluar algunas de las implicancias económicas de la Convención sobre Diversidad Biológica. Después de esbozar los principios más importantes y el enfoque de la Convención, se delinean los siguientes aspectos: la determinación del nivel "óptimo" de pérdida de biodiversidad, las consecuencias de la indeterminación del valor monetario de la biodiversidad y sus problemas con respecto del mecanismo de financiamiento, y se concluye con una discusión sobre el acceso a los recursos genéticos y a la biotecnología.

Suggested Citation

  • Frank G. Miller, 1997. "La Convención sobre Diversidad Biológica: una perspectiva de economía política," Apuntes. Revista de ciencias sociales, Fondo Editorial, Universidad del Pacífico, vol. 24(40), pages 111-131.
    • Handle: RePEc:pai:apunup:es-40-07
    as

    Download full text from publisher

    File URL: http://revistas.up.edu.pe/index.php/apuntes/article/download/458/460
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G. & Lasagna, Louis, 1991. "Cost of innovation in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 10(2), pages 107-142, July.
    2. James A. Swaney & Paulette I. Olson, 1992. "The Economics of Biodiversity: Lives and Lifestyles," Journal of Economic Issues, Taylor & Francis Journals, vol. 26(1), pages 1-25, March.
    3. Smith, Fraser, 1996. "Biological diversity, ecosystem stability and economic development," Ecological Economics, Elsevier, vol. 16(3), pages 191-203, March.
    4. Stahler, Frank, 1994. "Biological diversity: The international management of genetic resources and its impact on biotechnology," Ecological Economics, Elsevier, vol. 11(3), pages 227-236, December.
    5. Sedjo, Roger A, 1992. "Property Rights, Genetic Resources, and Biotechnological Change," Journal of Law and Economics, University of Chicago Press, vol. 35(1), pages 199-213, April.
    6. Timothy M. Swanson, 1994. "The International Regulation of Extinction," Palgrave Macmillan Books, Palgrave Macmillan, number 978-1-349-12985-0, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Gowdy, John M. & Ferreri Carbonell, Ada, 1999. "Toward consilience between biology and economics: the contribution of Ecological Economics," Ecological Economics, Elsevier, vol. 29(3), pages 337-348, June.
    2. Kohn, Robert E., 1999. "Thresholds and complementarities in an economic model of preserving and conserving biodiversity," Socio-Economic Planning Sciences, Elsevier, vol. 33(2), pages 151-172, June.
    3. Ding, Helen & Nunes, Paulo A.L.D. & Onofri, Laura, 2007. "An Economic Model for Bioprospecting Contracts," Sustainability Indicators and Environmental Valuation Working Papers 7450, Fondazione Eni Enrico Mattei (FEEM).
    4. D W Pearce, 1994. "The Great Environmental Values Debate," Environment and Planning A, , vol. 26(9), pages 1329-1338, September.
    5. Tisdell, Clem, 2003. "Socioeconomic causes of loss of animal genetic diversity: analysis and assessment," Ecological Economics, Elsevier, vol. 45(3), pages 365-376, July.
    6. Tisdell, Clem, 2011. "Biodiversity conservation, loss of natural capital and interest rates," Ecological Economics, Elsevier, vol. 70(12), pages 2511-2515.
    7. Scherer, F.M., 2010. "Pharmaceutical Innovation," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 539-574, Elsevier.
    8. Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022. "Generic competition and the incentives for early-stage pharmaceutical innovation," Research Policy, Elsevier, vol. 51(10).
    9. Palaniappan, Gomathy & King, Christine A. & Cameron, Don, 2009. "CS - Complexity Of Transition To Alternative Farming Systems," 17th Congress, Illinois State University, USA, July 19-24, 2009 345531, International Farm Management Association.
    10. Grabowski, Henry & Vernon, John & DiMasi, Joseph, 2002. "Returns on R&D for 1990s New Drug Introductions," Working Papers 02-21, Duke University, Department of Economics.
    11. Cardoso de Mendonca, Mario Jorge & Sachsida, Adolfo & Loureiro, Paulo R. A., 2003. "A study on the valuing of biodiversity: the case of three endangered species in Brazil," Ecological Economics, Elsevier, vol. 46(1), pages 9-18, August.
    12. DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
    13. Steven Casper;Hannah Kettler, 2000. "The Road to Sustainability in the UK and German Biotechnology Industries," Monograph 000466, Office of Health Economics.
    14. Clement A. Tisdell, 2014. "Sustainable agriculture," Chapters, in: Giles Atkinson & Simon Dietz & Eric Neumayer & Matthew Agarwala (ed.), Handbook of Sustainable Development, chapter 32, pages 517-531, Edward Elgar Publishing.
    15. Ramesh Govindaraj & Gnanaraj Chellaraj, 2002. "The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform," World Bank Publications - Books, The World Bank Group, number 15231.
    16. Schwartz, Eduardo S., 2002. "Patents and R& D as Real Options," University of California at Los Angeles, Anderson Graduate School of Management qt86b1n43k, Anderson Graduate School of Management, UCLA.
    17. Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
    18. Samira Guennif, 2007. "Global harmonisation of intellectual property rights and local impact. Patent and access to medicines in developing countries under TRIPS and TRIPS plus provisions [Harmonisation globale des systèm," Post-Print hal-01345869, HAL.
    19. Scherer, F. M., 2007. "Pharmaceutical Innovation," Working Paper Series rwp07-004, Harvard University, John F. Kennedy School of Government.
    20. Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pai:apunup:es-40-07. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Giit (email available below). General contact details of provider: https://edirc.repec.org/data/deiuppe.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.